Paid Clinical Trials Evansville

Discover 12 paid clinical trials in Evansville, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 12

Hintermann H3Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System

Recruiting

Sponsor:

DT MedTech, LLC

Location:

Evansville IN, Morrisville NC, Charleston SC, Oklahoma City OKshow 6 more

Code:

NCT04770870

Conditions

Osteoarthritis Ankle

Post-Traumatic Osteoarthritis of Ankle

Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Interventions

Hintermann Series H3 Total Ankle Replacement System

SebetralstatOpen-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Recruiting

PHASE3

Sponsor:

KalVista Pharmaceuticals, Ltd.

Location:

Evansville IN, Saint Louis MO, Birmingham AL, Toledo OHshow 7 more

Code:

NCT06467084

Conditions

Hereditary Angioedema

Eligibility Criteria

Sex: All

Age: 2 - 11

Healthy Volunteers: Not accepted

Interventions

KVD900 75 mg

KVD900 150 mg

KVD900 300 mg

Observational StudyC-Brace Prospective Registry

Recruiting

Sponsor:

Otto Bock Healthcare Products GmbH

Location:

Evansville IN, Fairview Heights IL, Saint Louis MO, Danville KYshow 47 more

Code:

NCT04640584

Conditions

Pareses

Lower Extremity

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

C-Brace

Observational StudyRegistry of the Patient Experience for Carpal Tunnel Release

Recruiting

Sponsor:

Sonex Health, Inc.

Location:

Evansville IN, Decatur IL, Saint Louis MO, Lexington KYshow 33 more

Code:

NCT06071468

Conditions

Carpal Tunnel Syndrome

CTS

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

UltraGuideCTR (Device) with Ultrasound Guided Carpal Tunnel Release (CTR-US)

Endocscopic CTR

Open CTR

LumateperoneMulticenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Evansville IN, Indianapolis IN, Saint Louis MO, Naperville ILshow 30 more

Code:

NCT06706674

Conditions

Irritability Associated With Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 5 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone high dose

Lumateperone low dose

Placebo

SPN-812Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Recruiting

Sponsor:

Supernus Pharmaceuticals, Inc.

Location:

Evansville IN, Owensboro KY, Bardstown KY, Cincinnati OHshow 37 more

Code:

NCT04781140

Conditions

Attention-Deficit/Hyperactivity Disorder

Eligibility Criteria

Sex: All

Age: 48 - 69

Healthy Volunteers: Not accepted

Interventions

100mg SPN-812

Placebo

KVD900PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Recruiting

PHASE3

Sponsor:

KalVista Pharmaceuticals, Ltd.

Location:

Evansville IN, Louisville KY, Saint Louis MO, Cincinnati OHshow 16 more

Code:

NCT05511922

Conditions

Hereditary Angioedema

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

KVD900 600 mg

Drug: KVD900 300 mg

EndoCheckDeep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

Recruiting

Sponsor:

Aspira Women's Health

Location:

Newburg IN, Cincinnati OH, Stockbridge GA, Columbus GAshow 7 more

Code:

NCT05245695

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 14 - 50

Healthy Volunteers: Not accepted

Interventions

Observational study, no intervention

RemibrutinibA Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Owensboro KY, Plainfield IN, River Forest IL, Glenview ILshow 27 more

Code:

NCT05976243

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Placebo

OM-85A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

Recruiting

PHASE2

Sponsor:

OM Pharma SA

Location:

Owensboro KY, Nashville TN, Indianapolis IN, Cincinnati OHshow 24 more

Code:

NCT05857930

Conditions

Recurrent Wheezing

Wheezing Lower Respiratory Illness

Eligibility Criteria

Sex: All

Age: 6 - 70+

Healthy Volunteers: Not accepted

Interventions

OM-85

Placebo